Position in LGND
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$6,903,098
+$1,659,242 QoQ
Shares Held
34,576
+24.7% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. LGND ranks #19 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503,564 | $224,861,468 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,152 | $84,335,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
171,797 | $56,842,473 | |
| 4 | INSM |
INSMED Inc
|
299,925 | $49,043,736 | |
| 5 | ARGX |
Argenx SE
|
61,418 | $44,850,494 | |
| 6 | RPRX |
Royalty Pharma plc
|
495,892 | $23,787,939 | |
| 7 | GMAB |
Genmab A/S
|
862,301 | $23,135,535 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
678,518 | $18,794,948 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,903,098 | 34,576 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $5,243,856 | 27,735 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,653,423 | 31,915 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,112,217 | 27,377 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,797,565 | 26,608 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $9,342,944 | 87,195 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,636,265 | 86,285 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,708,107 | 79,612 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,939,724 | 53,895 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,222,470 | 45,120 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,623,776 | 43,788 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,730,571 | 37,872 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $5,318,020 | 72,295 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,038,134 | 30,511 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,621,692 | 30,189 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,481,507 | 26,618 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,651,070 | 23,528 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,079,668 | 21,583 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,403,889 | 16,153 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,237,261 | 15,118 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $967,006 | 10,168 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $836,049 | 13,476 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,372,595 | 23,083 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,419,092 | 20,338 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $915,871 | 20,189 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||